Advertisement
Screener

Alexza Pharmaceuticals Inc. Financing Cash Flow

Alexza Pharmaceuticals Inc. Financing Cash Flow

Alexza Pharmaceuticals Inc. reported Financing Cash Flow of $38.51 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-05.

Discontinued › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2014-05-05

  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2014-03-31 was $38.51M, a 1026.71% increase year-over-year.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2013-12-31 was $4.39M.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2013-09-30 was $8.00M, a 39.52% decline year-over-year.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2013-06-30 was -$5.26M.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2013 was $10.55M, a 44.72% decline from fiscal 2012.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2012 was $19.08M, a 80.32% increase from fiscal 2011.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2011 was $10.58M, a 52.48% decline from fiscal 2010.
  • Alexza Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2010 was $22.27M, a 9.07% increase from fiscal 2009.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 12 monthNet Cash Provided by (Used in) Financing Activities 126 monthNet Cash Provided by (Used in) Financing Activities 129 monthNet Cash Provided by (Used in) Financing Activities 132 monthNet Cash Provided by (Used in) Financing Activities 135 monthNet Cash Provided by (Used in) Financing Activities 138 monthNet Cash Provided by (Used in) Financing Activities 141 month
2014-03-31$38.51M
10-Q · filed 2014-05-05
$42.90M
derived: sum of 2 quarters · filed 2014-05-05
$50.90M
derived: sum of 3 quarters · filed 2014-05-05
$45.64M
derived: sum of 4 quarters · filed 2014-05-05
2013-12-31$4.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
$12.39M
derived: sum of 2 quarters · filed 2014-03-25
$7.13M
derived: sum of 3 quarters · filed 2014-03-25
$10.55M
10-K · filed 2014-03-25
2013-09-30$8.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$2.74M
derived: sum of 2 quarters · filed 2013-11-06
$6.16M
10-Q · filed 2013-11-06
$6.05M
derived: sum of 4 quarters · filed 2014-05-05
2013-06-30-$5.26M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
-$1.84M
10-Q · filed 2013-08-14
-$1.95M
derived: sum of 3 quarters · filed 2014-05-05
$11.28M
derived: sum of 4 quarters · filed 2014-05-05
2013-03-31$3.42M
10-Q · filed 2014-05-05
$3.31M
derived: sum of 2 quarters · filed 2014-05-05
$16.54M
derived: sum of 3 quarters · filed 2014-05-05
$16.40M
derived: sum of 4 quarters · filed 2014-05-05
2012-12-31-$107.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
$13.12M
derived: sum of 2 quarters · filed 2014-03-25
$12.98M
derived: sum of 3 quarters · filed 2014-03-25
$19.08M
10-K · filed 2014-03-25
2012-09-30$13.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06
$13.09M
derived: sum of 2 quarters · filed 2013-11-06
$19.19M
10-Q · filed 2013-11-06
$17.73M
derived: sum of 4 quarters · filed 2014-03-25
$356.01M
10-Q · filed 2012-11-06
2012-06-30-$142.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$5.96M
10-Q · filed 2013-08-14
$4.50M
derived: sum of 3 quarters · filed 2014-03-25
$3.03M
derived: sum of 4 quarters · filed 2014-03-25
$342.78M
10-Q · filed 2012-08-08
2012-03-31$6.10M
10-Q · filed 2013-05-14
$4.64M
derived: sum of 2 quarters · filed 2014-03-25
$3.17M
derived: sum of 3 quarters · filed 2014-03-25
$17.84M
derived: sum of 4 quarters · filed 2014-03-25
$342.93M
10-Q · filed 2012-05-10
2011-12-31-$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25
-$2.93M
derived: sum of 2 quarters · filed 2014-03-25
$11.74M
derived: sum of 3 quarters · filed 2014-03-25
$10.58M
10-K · filed 2014-03-25
$336.82M
10-K · filed 2012-03-12
2011-09-30-$1.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06
$13.20M
derived: sum of 2 quarters · filed 2012-11-06
$12.04M
10-Q · filed 2012-11-06
$11.82M
derived: sum of 4 quarters · filed 2013-03-26
$338.28M
10-Q · filed 2011-11-07
2011-06-30$14.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08
$13.52M
10-Q · filed 2012-08-08
$13.30M
derived: sum of 3 quarters · filed 2013-03-26
$30.33M
derived: sum of 4 quarters · filed 2013-03-26
$339.76M
10-Q · filed 2011-08-08
2011-03-31-$1.16M
10-Q · filed 2012-05-10
-$1.38M
derived: sum of 2 quarters · filed 2013-03-26
$15.65M
derived: sum of 3 quarters · filed 2013-03-26
2010-12-31-$216.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-26
$16.82M
derived: sum of 2 quarters · filed 2013-03-26
$22.27M
10-K · filed 2013-03-26
2010-09-30$17.03M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$22.48M
10-Q · filed 2011-11-07
2010-06-30$5.45M
10-Q · filed 2011-08-08
2009-12-31$20.42M
10-K · filed 2012-03-12